KR102035812B1 - Hair growth promoter - Google Patents
Hair growth promoter Download PDFInfo
- Publication number
- KR102035812B1 KR102035812B1 KR1020157032937A KR20157032937A KR102035812B1 KR 102035812 B1 KR102035812 B1 KR 102035812B1 KR 1020157032937 A KR1020157032937 A KR 1020157032937A KR 20157032937 A KR20157032937 A KR 20157032937A KR 102035812 B1 KR102035812 B1 KR 102035812B1
- Authority
- KR
- South Korea
- Prior art keywords
- hair
- adenine
- growth promoter
- hair growth
- cosmetic carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 모발 성장 촉진제에 관한 것으로, 아데닌이나 아데닌 염류의 활성물질 및 화장품 담체를 포함한다. 상기 활성 물질은 성분 물질 백분비의 0.0001% 이상을 차지하며, 상기 화장품 담체는 윤활제, 용제, 보습제나 증조제로서 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸등 관련 제품에 응용할 수 있다. 본 발명은 비단 모발 성장을 자극하고, 탈모 방지 효과가 있을 뿐 아니라, 속눈썹과 눈썹 성장을 촉진하는 효과도 있다. The present invention relates to a hair growth promoter, and includes an active material of adenine or adenine salts and a cosmetic carrier. The active substance accounts for more than 0.0001% of the component substance percentage, and the cosmetic carrier can be applied to related products such as hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo as lubricant, solvent, moisturizer or thickener. . The present invention stimulates silk hair growth and has the effect of preventing hair loss, as well as promoting eyelash and eyebrow growth.
Description
본 발명은 일종의 모발 성장 촉진제에 관한 것이며, 특히 일종의 모발 성장 유지 및 그 조밀도를 증가시키는 모발 성장 촉진제를 말한다.The present invention relates to a kind of hair growth promoter, and in particular, refers to a kind of hair growth promoter that maintains a kind of hair growth and increases its density.
현대 인구의 노령화 및 생활 스트레스가 나날이 증가함에 따라 갈수록 많은 사람들이 탈모나 대머리의 위기에 직면하고 있다. 의학 연구에 근거하면 이러한 위기감은 가정의 심리적 및 정서적 스트레스도 일으키기 때문에, 대부분의 사람들은 대머리 증상을 효과적으로 치료할 수 있는 방법을 찾고 있다. 일반적으로 탈모는 남성 호르몬과 모낭속의 디하이드로테스토스테론이 일으키는 것으로, 디하이드로테스토스테론은 모낭과 모발 진피층 유두상 돌기의 혈유량을 감소시켜 두피 양분의 부족이나 산화 반응을 일으킨다. 그러므로 일반 발모액 비방에는 상술한 증상을 제거하거나 완화시키는 성분을 포함하고 있다. 예를 들면, 당약 추출액, 비타민 E 및 그 유도체 또는 포스파티딜 콜린 유도체를 첨가하여 두피의 혈액 순환을 증가시키거나 또는 모낭에 영양을 공급하는 세인이나 메티오닌같은 아미노산, B6같은 비타민등을 첨가하여 탈모를 예방하고 모발 성장을 촉진시킨다.As the aging and living stresses of the modern population increase day by day, more and more people are facing hair loss or baldness. Based on medical research, this crisis also creates psychological and emotional stress at home, so most people are looking for ways to effectively treat baldness. In general, hair loss is caused by male hormones and dihydrotestosterone in the hair follicles. Dihydrotestosterone reduces the blood flow of hair follicles and papillary papillary process of hair follicles, causing scalp nutrients and oxidative reactions. Therefore, general hair restorer slurries contain ingredients that eliminate or alleviate the above symptoms. For example, sugar extracts, vitamin E and its derivatives or phosphatidylcholine derivatives can be added to increase the blood circulation of the scalp or nutrients to hair follicles, amino acids such as sane or methionine, and vitamins such as B6 to prevent hair loss. And promote hair growth.
미국 식품 약물 관리국은 (FDA) 남성 대머리 증상을 치료할 수 있는 두가지 성분을 제시했는데, 각각 피나스테라이드(finasteride,미국 특허 번호 2006/0099251 A1) 및 미녹시딜 (minoxidil,미국 특허 번호 4139619)이다. 피나스테라이드(finasteride)는 활성화된 5 알파 리덕테이스 억제를 이용해 유리 테스토스테론을 디하이드로테스토스테론으로 전환시켜서 모낭 소형화를 야기시키는 것이다(Dallob,1994년). 이것은 원래 양성 전립선 비대증 (BHP) 치료용이었으나 나중에 남성 대머리 증상 치료에도 효과가 있다는 사실을 발견하였다. 미녹시딜(minoxidil)은 일종의 혈관 확장제로서, 원래는 고혈압을 치료하는 일종의 경구용 약물이었으나(Loniten),1980년대 그 부작용으로 두발 성장 및 탈모 억제 효과를 발견하였다. 업존사는 FDA 승인을 얻어 대머리 증상과 탈모증을(Rogaine and Regaine)효과적으로 치료하는 미녹시딜 (minoxidil)이 2% 함유된 제품을 출시하였다. 그 효과는 혈관 확대와 칼륨 채널 개방을 통해 산소와 혈액, 양분을 모낭속으로 더욱 많이 진입시키기 때문이다. 미녹시딜 (minoxidil) 발모액은 아데노신과 함께 사용을 추천하고 있고(Li,2001년),A2b 아데노신을 수용체 경로로 사용할 수 있다(Iino,2007년). 그러므로 아데노신 역시 대머리 증상을 치료할 수 있는 기능을 가지고 있는 것으로 밝혀졌다. 그러나 부작용이 발생할 수 있는데, 특히 미녹시딜 (minoxidil)과 아데노신을 함께 사용하면 부종이나 심장 박동이 빨라지고, 호흡 곤란, 피로감과 매스꺼움등이 발생할 수 있고, 발암을 야기할 수도 있다. The US Food and Drug Administration (FDA) has suggested two ingredients to treat male baldness, finasteride (US Patent No. 2006/0099251 A1) and minoxidil (US Patent No. 4139619), respectively. Is to convert free testosterone to dihydrotestosterone using activated 5 alpha reductase suppression, causing hair follicle miniaturization (Dallob, 1994), which was originally intended to treat benign prostatic hyperplasia (BHP), but later to treat male baldness. Minoxidil was a type of vasodilator, originally an oral drug for the treatment of hypertension (Loniten), but the side effects of the 1980s were found to inhibit hair growth and hair loss. Baldness and hair loss with FDA approval Launched a product that contains 2% minoxidil, an effective treatment for rogaine and regaine, because it allows more oxygen, blood and nutrients to enter the hair follicle through vasodilation and potassium channel opening. Minoxidil hair regrowth is recommended for use with adenosine (Li, 2001), and A2b adenosine can be used as a receptor pathway (Iino, 2007), so adenosine also has the ability to treat baldness. However, side effects can occur, especially when minoxidil and adenosine are used together, resulting in faster edema and heart rate, shortness of breath, fatigue and nausea, and even carcinogenesis.
비록 상술한 각종 방법을 사용해 보았지만, 현재 시중에 나와있는 발모액은 아직 두피의 어느 구역에서도 충분하게 탈모 방지와 모발 성장을 촉진할 수 있는 효과를 갖추지 못하고 있다. 예를 들면, 정수리나 이마에 피나스테라이드(finasteride)와 미녹시딜 (minoxidil)을 사용하면 거의 정수리의 모발에만 성장 효과가 있다. 또한 대부분의 치료는 반드시 장시간이 지나야만 효과가 나타나는데, 예를 들면, 4개월에서 6개월 정도가 필요하다. 대머리 증상 치료 역시 모발 이식 수술을 통해 문제를 해결할 수는 있지만, 수술 과정중 통증이 있고, 또 반드시 성공을 보장할 수도 없으며, 심지어 수개월에서 수년이 지나야만 두발이 재생된다. Although the various methods described above have been used, the hair regrowth on the market is not yet effective enough to prevent hair loss and promote hair growth in any area of the scalp. For example, the use of finasteride and minoxidil on the parietal or forehead has a growth effect on almost parietal hair. In addition, most treatments are only effective after a long time, for example, four to six months is required. Bald symptomatic treatment can also solve the problem through hair transplantation, but there is pain during the procedure, and it does not necessarily guarantee success, and even after months or years, the hair is regenerated.
이러한 점을 감안하여, 본 발명의 목적은 일종의 모발 성장 촉진제의 제공에 있다.In view of these points, an object of the present invention is to provide a kind of hair growth promoter.
본 발명은 일종의 모발 성장 촉진제를 제공하며, 상술한 모발 성장 촉진제는아데닌이나 아데닌 염류의 활성 물질, 및 화장품 담체이다.The present invention provides a kind of hair growth promoter, wherein the hair growth promoter described above is an active substance of adenine or adenine salts, and a cosmetic carrier.
상술한 일종의 모발 성장 촉진제의 최적화 방안으로서, 그중 상술한 모발 성장 촉진제는 아데닌이나 아데닌 염류를 통해 화장품 담체와 혼합해서 사용한다. As an optimization method of the kind of hair growth promoter described above, the hair growth promoter described above is used in admixture with a cosmetic carrier through adenine or adenine salts.
상술한 일종의 모발 성장 촉진제의 최적화 방안으로서, 그중 상술한 활성화 물질은 모발 성장 촉진제 중량 백분비의 0.0001% 이상 내지 0.05% 미만을 차지한다.As an optimization method of the kind of hair growth promoter described above, the above-mentioned activating material accounts for at least 0.0001% and less than 0.05% of the hair growth accelerator weight percentage.
상술한 일종의 모발 성장 촉진제의 최적화 방안으로서, 그중 상술한 화장품 담체는 윤활제, 용제, 보습제, 증조제, 분말이나 그 혼합물이다. As an optimization method of the kind of hair growth promoter mentioned above, the above-mentioned cosmetic carrier is a lubricant, a solvent, a moisturizer, a thickener, a powder, or its mixture.
상술한 일종의 모발 성장 촉진제의 최적화 방안으로서, 그중 상술한 화장품 담체는 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸이다.As an optimization method of the kind of hair growth promoter described above, the above-mentioned cosmetic carriers are hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo.
본 발명은 일종의 속눈썹과 눈썹의 성장 촉진제를 제공하며, 상술한 속눈썹과 눈썹 성장 촉진제의 성분인 아데닌이나 아데닌 염류의 활성 물질; 및 화장품 담체를 포함한다. The present invention provides a kind of eyelash and eyebrow growth accelerator, the active material of adenine or adenine salts as a component of the eyelash and eyebrow growth promoter described above; And cosmetic carriers.
상술한 일종의 속눈썹과 눈썹 성장 촉진제의 최적화 방안으로서, 그중 상술한 화장품 담체는 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸이다.As an optimization method of the above-described types of eyelashes and eyebrow growth promoters, the above-mentioned cosmetic carriers are hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo.
본 발명은 일종의 탈모 방지제를 제공하며, 상술한 탈모 방지제는 아데닌이나 아데닌 염류의 활성 물질, 및 화장품 담체를 포함한다.The present invention provides a kind of hair loss preventing agent, and the aforementioned hair loss preventing agent includes an active substance of adenine or adenine salts, and a cosmetic carrier.
상술한 일종의 탈모 방지제의 최적화 방안으로서, 그중 상술한 화장품 담체는 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸이다.As the above-mentioned optimization method of the anti-hair loss agent of the kind, the above-mentioned cosmetic carrier is a hair regrowth liquid, a hair clean lotion, a rinse, a conditioner, a hair spray, or a shampoo.
본 발명의 모발 성장 촉진제는 아데닌이나 아데닌 염류를 통해 활성 물질로 삼는다, 및 화장품 담체, 인체 피부나 두피에 해를 끼치지 않는 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸를 제공하며, 비단 모발 성장을 자극시키고 탈모를 방지할 뿐 아니라, 심지어 속눈썹과 눈썹 성장을 촉진시키는 효능도 있다.The hair growth promoter of the present invention is used as an active substance through adenine or adenine salts, and provides a cosmetic carrier, hair regrowth that does not harm human skin or scalp, hair clean lotion, rinse, conditioner, hair spray or shampoo. It not only stimulates hair growth and prevents hair loss, but also promotes eyelash and eyebrow growth.
도 1은 본 발명의 모발 진피 유상 돌기세포 재생 테스트 비교도이다.1 is a comparative diagram of the hair dermal dermal papilla regeneration test of the present invention.
상술한 목적 및 효능을 달성하기 위해, 아래와 같이 도면과 실시예를 통해 설명함으로써, 본 분야의 일반적 기술자들이 아래 설명에 근거해 본 발명을 실시할 수 있도록 하였다. In order to achieve the above object and effect, it will be described through the following drawings and examples, to enable those skilled in the art to practice the present invention based on the following description.
먼저 본 발명이 제공하는 일종의 모발 성장 촉진제는 아데닌이나 아데닌 염류의 활성 물질 및 화장품 담체를 포함하며, 그 활성 물질의 비율은 배합 형태, 제작 방법에 따라 다르고, 그 성분 중량 백분비의 비교적 우수한 범위는 0.0001% 이상 내지 0.05% 미만이다. 그 모발 성장 촉진제는 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이나 샴푸 등의 형식을 통해 존재할 수 있고, 액체나 크림, 로션을 통해 피부나 두피에 바를 수 있다. 또한 본 발명이 포함하는 화장품 담체는 희석제, 분산제나 아데닌의 담체일 수 있고, 모발 성장 촉진제의 성분이 피부 표면에 평균적으로 분포될 수 있도록 촉진하며, 담체의 형태는 액체나 고체 윤활제, 용제, 보습제, 증조제나 분말일 수 있다. 본 발명의 활성 물질과 화장품 담체 이외에 모발 성장 촉진제는 친수성 또는 친유성 젤, 친수 또는 친유 활성제, 방부제, 항산화제, 용제, 향료, 필러, 살균제, 방취제, 염료와 착색제등과 같이 화장품이나 약물, 피부 분야에 일반적으로 사용하는 첨가제와 보조제도 포함할 수 있으며, 이러한 첨가제와 보조제의 사용 범위는 총중량 백분비의 0.01%에서 10%이다.First, a kind of hair growth promoter provided by the present invention includes an active substance of adenine or adenine salt and a cosmetic carrier, and the ratio of the active substance varies depending on the compounding form and production method, and the relatively good range of the weight percentage of the component is 0.0001. More than% and less than 0.05%. The hair growth promoter may be in the form of hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo, and may be applied to the skin or scalp through liquids, creams, or lotions. In addition, the cosmetic carrier included in the present invention may be a diluent, a dispersant or a carrier of adenine, and promotes the distribution of the components of the hair growth promoter on the surface of the skin on an average, and the form of the carrier is a liquid or a solid lubricant, a solvent, a humectant. It may be a thickener or a powder. In addition to the active substances and cosmetic carriers of the present invention, hair growth promoters may be used in cosmetics, drugs, skin, such as hydrophilic or lipophilic gels, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, flavorings, fillers, fungicides, deodorants, dyes and coloring agents, and the like. Additives and auxiliaries commonly used in the art may also be included and the range of use of these additives and auxiliaries is from 0.01% to 10% of the total weight percentage.
본 발명중 아데닌이나 아데닌 염류 함량의 모발 성장 효과에 대한 영향력을 증명하기 위해, 본 발명의 모발 성장 촉진제는 다양한 비율 배합을 통해 발모 수용액 샘플 4가지를 만들었으며, 그 성분 비율은 표 1과 같고, 그 샘플 배합 방법은 다음을 포함한다: In order to prove the influence on the hair growth effect of the adenine or adenine salt content in the present invention, the hair growth promoter of the present invention made four samples of aqueous solution of hair growth through various ratio combinations, the component ratios are shown in Table 1, The sample formulation method includes:
(1) 아데닌 황산염을 멘톨, 폴리에틸렌 글리콜 -40, 하이드로제네이티드 캐스터오일, 에탄올 및 이온 교화수 일부와 혼합 섞어서 용액을 만든다.(1) Mix adenine sulfate with menthol, polyethylene glycol-40, hydrogenated castor oil, ethanol and a portion of ionic water to make a solution.
(2) 다시 그 나머지 이온 교환수를 상술한 용액속에 첨가하여 발모 수용액을 만든다.(2) The remaining ion-exchanged water is further added to the above-described solution to form an aqueous hair growth solution.
(a)생쥐에 대한 발모 테스트 실시(a) Conduct hair growth test on mice
상술한 샘플 1-4를 모발 성장 사이클이 이미 정지된 생쥐의 몸에 발라서 테스트를 실시했다. 이 생쥐들은 이미 가위나 면도칼로 그 등의 모발을 깎아낸 후, 샘플 1에서 4의 발모액을 모발을 깎아낸 그 등 부분에 발라주었다. 생쥐 10마리를 한 조로 하고, 각 조마다 매일 0.2밀리리터 용량의 샘플을 1회 발라주었으며, 14일과 28일이 경과한후 그 모발 재생 구역 비율의 평균 수치는 표 2와 같다. Samples 1-4 described above were applied to the body of mice in which the hair growth cycle had already been stopped and tested. These mice have already shaved off their back with scissors or a razor, and then applied sample hairs from samples 1 to 4 on their backs. Ten mice were used as a group, and 0.2 milliliter doses were applied once daily in each group, and the average value of the hair regeneration zone ratio after 14 and 28 days is shown in Table 2.
표 2 결과로부터 볼 수 있듯이, 아데닌 황산염을 첨가한 샘플 2,3,4가 샘플 1보다 뚜렷한 효과를 보이고 있어서, 본 발명의 모발 성장 촉진제 성분이 모발 성장에 대해 매우 탁월한 효과가 있다는 것을 미루어 알 수 있다.As can be seen from the results of Table 2, samples 2, 3, and 4 with the addition of adenine sulphate show a more pronounced effect than sample 1, indicating that the hair growth promoter component of the present invention has a very excellent effect on hair growth. have.
(b)인체에 대한 발모 테스트 실시(b) Conduct hair growth test on the human body
본 발명은 탈모 방지 및 두발 성장 촉진 효과를 가지고 있으며, 위와 같이 배합한 샘플 3, 샘플 4와 제어 그룹을 대머리 증상을 가진 남자 60명의 두피에 발라주었다. 1일 2회, 매번 1ml의 용량을 연속 4개월 발라준 후, 설문 방식으로 인체 테스트 조사를 실시하였으며, 그 설문 조사 테스트 결과는 표 3과 같다.The present invention has a hair loss prevention and hair growth promoting effect, and the combination of the sample 3, sample 4 and the control group was applied to the scalp of 60 men with bald symptoms. Twice a day, 1ml each time for a continuous four months after applying a human test survey was conducted, the survey test results are shown in Table 3.
표 3의 결과에서 알 수 있듯이, 본 발명의 모발 성장 촉진제는 두발 성장에 대해 뚜렷한 치료 효과를 지닌 아데닌이나 아데닌 염류를 함유하고 있다.As can be seen from the results in Table 3, the hair growth promoter of the present invention contains adenine or adenine salts having a distinct therapeutic effect on hair growth.
(c) 헤어 클린 로션의 배합을 실시한다.(c) Blend hair clean lotion.
그 제조 방법 및 성분은 아래 및 표 4를 참조한다.See below and Table 4 for their preparation methods and components.
(c-1) 제 1 단계와 제 2 성분을 각각 혼합해 용액으로 만든다.(c-1) The first step and the second component are respectively mixed to form a solution.
(c-2) 상술한 용액 혼합제를 헤어 클린 로션으로 만든다.(c-2) The above-mentioned solution mixture is made into hair clean lotion.
(d) 샴푸의 배합을 실시한다(d) Formulate shampoo
그 제조 방법 및 성분은 아래 및 표 5를 참조한다.See below and Table 5 for their preparation methods and components.
(d-1) 교반기로 하이드록시셀루로오스(hydroxycellulose)를 이온 교환수속에서 균일하게 분포시킨다.(d-1) The hydroxycellulose is uniformly distributed in the ion exchange water with a stirrer.
(d-2) 상술한 용액을70℃로 가열한 후, 에틸렌디아민테트라 아세트산 디소디움염과 나트륨 시트르산을 완전히 용해될 때까지 첨가한다.(d-2) After heating the above-mentioned solution to 70 degreeC, ethylene diamine tetra acetate disodium salt and sodium citric acid are added until it melt | dissolves completely.
(d-3) 상술한 용액에 폴리쿼터늄-7을 완전히 용해될 때까지 첨가한다.(d-3) Polyquaternium-7 is added to the solution described above until it is completely dissolved.
(d-4) 상술한 용액을40℃로 냉각시킨후, 소듐라우로일 사코시네이트(Sodium laurosyl), 라우라미도프로필베타인(lauric acid amido propylbetaine), 코크아미도 프로필아민 산화물(Cocamidopropylamine oxide)과 라우라마이드 MEA(Lauramide MEA)를 첨가하고 혼합시킨다.(d-4) After cooling the above-mentioned solution to 40 ° C, sodium laurosyl, sodium laurosyl, lauric acid amido propylbetaine, cocamidopropylamine oxide And lauramide MEA are added and mixed.
(d-5) 요소, 프로필파라벤, 아데닌 황산염, 멘톨과 향료를 첨가하여 샴푸를 만든다.(d-5) Add urea, propylparaben, adenine sulfate, menthol and flavoring to make a shampoo.
(e) 린스 배합 실시(e) Rinse formulation
그 제작 방법 및 성분은 표 6과 같다. 이온 교환수와 폴리쿼터늄-7을 완전히 혼합한 후, 구아하이드록시프로필트리모늄클로라이드, 디메티콘 코폴리올, 아데닌 황산염과 향료를 첨가하여 린스를 만든다.The preparation method and components are shown in Table 6. After thoroughly mixing ion-exchanged water and polyquaternium-7, rinse is added by adding guarhydroxypropyltrimonium chloride, dimethicone copolyol, adenine sulfate and flavoring.
(f) 눈썹과 속눈썹 클린 로션 배합을 실시한다.(f) Apply eyebrow and eyelash clean lotion.
그 제조 방법 및 성분은 아래 및 표 7을 참조한다. See below and Table 7 for their preparation methods and components.
(f-1) 제 1 단계와 제 2 단계 성분을 각각 혼합해서 용액을 만든다.(f-1) A solution is prepared by mixing the first and second components, respectively.
(f-2) 다시 상술한 용액을 혼합하여 눈썹과 속눈썹 클린 로션을 만든다. (f-2) Again, the above solution is mixed to make eyebrow and eyelash clean lotion.
(g) 속눈썹 클린 로션의 인체 테스트 실시(g) human body test of eyelash clean lotion
본 발명의 속눈썹 클린 로션은 아래 설문 조사 방식으로 인체 테스트 조사를 실시하였으며, 그 테스트는 테스트 대상인 여성 48명의 속눈썹에 상술한 배합의 샘플 8, 샘플 9와 제어그룹 2를 면봉으로 하루에 1회, 0.5ml 용량을 연속 3개월 발라주었으며, 그 설문 테스트 결과는 표 8과 같다. The eyelash clean lotion of the present invention was subjected to a human test investigation by the following survey method, and the test was performed once a day with a swab of the sample 8, 9, and the control group 2 of the above-described combination on the eyelashes of 48 women to be tested. 0.5 ml dose was applied for 3 consecutive months, and the results of the questionnaire test are shown in Table 8.
표 8의 결과에서 알 수 있듯이, 본 발명의 속눈썹 클린 로션의 성분은 속눈썹 성장에 뚜렷한 효과가 있는 아데닌이나 아데닌 염류를 함유한다.As can be seen from the results in Table 8, the components of the eyelash clean lotion of the present invention contain adenine or adenine salts which have a distinct effect on eyelash growth.
(h)눈썹 클린 로션의 인체 테스트 실시(h) Human body test of eyebrow clean lotion
본 발명의 눈썹 클린 로션은 아래 설문 조사 방식으로 인체 테스트 조사를 실시하였으며, 그 테스트는 테스트 대상인 여성 60명의 눈썹에 상술한 배합의 샘플 8, 샘플 9와 제어그룹 2를 면봉으로 하루에 1번, 0.5ml 용량을 연속 2개월 발라주었으며, 그 설문 테스트 결과는 표 9과 같다.The eyebrow clean lotion of the present invention was subjected to a human body test by the following questionnaire method, and the test was performed once a day with a swab of the sample 8, 9 and the control group 2 of the above-described combination on the eyebrows of 60 women to be tested. 0.5 ml dose was applied for 2 consecutive months, and the results of the questionnaire test are shown in Table 9.
표 9의 결과에서 알 수 있듯이, 본 발명의 눈썹 클린 로션의 성분은 눈썹 성장에 뚜렷한 효과가 있는 아데닌이나 아데닌 염류를 함유한다.As can be seen from the results of Table 9, the components of the eyebrow clean lotion of the present invention contain adenine or adenine salts that have a distinct effect on eyebrow growth.
(i) 모발 진피 유두상 돌기세포 재생 테스트(i) Hair dermal papillary dendritic cell regeneration test
아데닌이 향상시키는 세포 재생 효과를 통해 사람의 모발 진피 유두상 돌기세포의 수량을 헤아릴 수 있다. 아래 조건하에서 아데노신과 minoxidil (미녹시딜)의 작용을 비교했으며, 그 결과는 표 1과 같다. 모발 진피 유두상 돌기세포의 세포 배양액중에 함유된 아데닌, 아데노신과 minoxidil (미녹시딜)을 측정했으며, 성분중에 0.002%의 아데닌, 아데노신과 minoxidil (미녹시딜)을 함유하고 있고, 그 측정 방법은 다음과 같다:The cell renewal effect of adenine can be used to estimate the number of human dermal papillary dendritic cells. The action of adenosine and minoxidil (minoxidil) was compared under the following conditions, and the results are shown in Table 1. Adenine, adenosine and minoxidil (minoxidil) contained in the cell cultures of hair dermal papillary dendritic cells were measured and contained 0.002% of adenine, adenosine and minoxidil (minoxidil), and the measuring method was as follows:
(i-1) 0.002%의 아데닌, 아데노신과 미녹시딜(minoxidil)을 배합하고, 모발 진피 유두상 돌기세포의 매개체를 제어 측정한다.(i-1) 0.002% of adenine, adenosine and minoxidil are combined to control the media of hair dermal papillary dendritic cells.
(i-2) 사람의 모발 진피 유두상 돌기세포를 배양접시 96셀에 각각 이식하고, 그 밀도는 5000개 세포/ 셀이며, 0.1ml의 배양액을 각 셀의 배양접시속에 첨가한다.(i-2) Human hair dermal papillary dendritic cells are transplanted into 96 cells of a culture dish, the density of which is 5000 cells / cell, and 0.1 ml of the culture solution is added to the culture dish of each cell.
(i-3) 이식 세포 12, 24, 36, 48과 60시간후 다시 비주얼 카운터로 모든 세포의 수량을 계산한다.(i-3) After 12, 24, 36, 48 and 60 hours of transplantation cells, count the quantity of all cells again with the visual counter.
(i-4) 도 1의 결과에서 알 수 있듯이, 아데닌이 사람의 모발 진피 유두상 돌기세포의 재생 능력을 뚜렷하게 향상시키기 때문에, 본 발명의 모발 재생 촉진제는 뚜렷한 헤어 케어 효과를 갖고 있어 인류나 포유류의 모발 성장 능력을 향상시키고, 탈모를 예방할 수 있다.(i-4) As can be seen from the results of Fig. 1, since the adenine significantly improves the regeneration ability of human hair dermal papillary dendritic cells, the hair regeneration promoter of the present invention has a distinct hair care effect, which leads to humans and mammals. Can improve hair growth ability and prevent hair loss.
상술한 내용을 종합하면, 이는 본 발명의 비교적 우수한 실시예로서, 이로 인해 본 발명의 특허 청구 범위로 국한될 수 없으며, 본 발명의 특허 청구 범위는 청구항의 내용을 기준으로 한다.In summary, this is a comparatively good embodiment of the present invention, which is not limited to the claims of the present invention, and the claims of the present invention are based on the contents of the claims.
Claims (6)
모발 성장 촉진에 효과적인 유일한 활성 성분으로서 아데닌 또는 아데닌 염류; 및 화장품 담체;로 구성되고,
모발 성장 촉진제 중량을 기준으로 한 상기 활성 성분의 함량이 0.002 중량%와 0.01 중량% 사이의 범위 이내인,
모발 성장 촉진제.As a hair growth promoter,
As the only active ingredient effective for promoting hair growth, adenine or adenine salts; And a cosmetic carrier;
The content of the active ingredient based on the weight of the hair growth promoter is within the range between 0.002% and 0.01% by weight,
Hair growth promoter.
속눈썹 및 눈썹 성장 촉진에 효과적인 유일한 활성 성분으로서 아데닌 또는 아데닌 염류; 및 화장품 담체;로 구성되고,
속눈썹 및 눈썹 성장 촉진제 중량을 기준으로 한 상기 활성 성분의 함량이 0.002 중량%와 0.01 중량% 사이의 범위 이내이며,
상기 화장품 담체가 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이 또는 샴푸인,
속눈썹 및 눈썹 성장 촉진제.As eyelash and eyebrow growth promoter,
As the only active ingredient effective for promoting eyelash and eyebrow growth, adenine or adenine salts; And a cosmetic carrier;
The content of the active ingredient based on the weight of the eyelashes and eyebrow growth promoter is within the range between 0.002% and 0.01% by weight,
The cosmetic carrier is a hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo,
Eyelash and Eyebrow Growth Accelerators.
탈모 방지에 효과적인 유일한 활성 성분으로서 아데닌 또는 아데닌 염류; 및 화장품 담체;로 구성되고,
탈모 방지제 중량을 기준으로 한 상기 활성 성분의 함량이 0.002 중량%와 0.01 중량% 사이의 범위 이내이며,
상기 화장품 담체가 발모액, 헤어 클린 로션, 린스, 컨디셔너, 두발 스프레이 또는 샴푸인,
탈모 방지제.As a hair loss prevention agent,
As the only active ingredient effective in preventing hair loss, adenine or adenine salts; And a cosmetic carrier;
The content of the active ingredient based on the weight of the hair loss preventing agent is within a range between 0.002% and 0.01% by weight,
The cosmetic carrier is a hair regrowth, hair clean lotion, rinse, conditioner, hair spray or shampoo,
Hair loss prevention agent.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/078935 WO2012068714A1 (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020137009608A Division KR20130060326A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020187019007A Division KR20180080368A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150136544A KR20150136544A (en) | 2015-12-07 |
KR102035812B1 true KR102035812B1 (en) | 2019-10-23 |
Family
ID=46145345
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020137009608A Ceased KR20130060326A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
KR1020157032937A Active KR102035812B1 (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
KR1020187019007A Withdrawn KR20180080368A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020137009608A Ceased KR20130060326A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020187019007A Withdrawn KR20180080368A (en) | 2010-11-22 | 2010-11-22 | Hair growth promoter |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5902184B2 (en) |
KR (3) | KR20130060326A (en) |
WO (1) | WO2012068714A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016056644A1 (en) * | 2014-10-09 | 2016-04-14 | 株式会社メディプロデュース | Eyelash cleaning agent |
CN113827608A (en) * | 2021-09-18 | 2021-12-24 | 福州博德新材料科技有限公司 | Purine nucleoside-containing efficient minoxidil hair-growing tincture and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101217999A (en) | 2005-07-08 | 2008-07-09 | 宝洁公司 | Personal care compositions and methods for beautification of mammalian skin and hair |
CN100471502C (en) | 2002-04-09 | 2009-03-25 | 大塚制药株式会社 | Composition for cell proliferation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139619A (en) | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
JP2855274B2 (en) * | 1989-10-19 | 1999-02-10 | 株式会社コーセー | Hair restoration |
JPH06128125A (en) * | 1992-10-14 | 1994-05-10 | Kose Corp | Hair tonic |
IS6633A (en) | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Compositions of finasteride tablets |
CN1878530A (en) * | 2003-11-11 | 2006-12-13 | 株式会社资生堂 | Method and composition for hair thickening |
JP2006076984A (en) * | 2004-09-07 | 2006-03-23 | Kaoru Suzuki | Hair-growing/restoring agent |
JP2006290767A (en) * | 2005-04-07 | 2006-10-26 | Lucia:Kk | Hair-fostering/growing agent |
JP2007045712A (en) * | 2005-08-05 | 2007-02-22 | Lion Corp | Scalp and hair cosmetic |
WO2007074602A1 (en) * | 2005-12-26 | 2007-07-05 | Lion Corporation | Cosmetic for scalp and hair |
DE102006042231A1 (en) * | 2006-09-06 | 2008-03-27 | Henkel Kgaa | Agent containing biochinones and purine or purine derivatives |
JP2010184916A (en) * | 2009-02-13 | 2010-08-26 | Pias Arise Kk | Hair growth promoter |
-
2010
- 2010-11-22 KR KR1020137009608A patent/KR20130060326A/en not_active Ceased
- 2010-11-22 KR KR1020157032937A patent/KR102035812B1/en active Active
- 2010-11-22 JP JP2013534147A patent/JP5902184B2/en active Active
- 2010-11-22 WO PCT/CN2010/078935 patent/WO2012068714A1/en active Application Filing
- 2010-11-22 KR KR1020187019007A patent/KR20180080368A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100471502C (en) | 2002-04-09 | 2009-03-25 | 大塚制药株式会社 | Composition for cell proliferation |
CN101217999A (en) | 2005-07-08 | 2008-07-09 | 宝洁公司 | Personal care compositions and methods for beautification of mammalian skin and hair |
Also Published As
Publication number | Publication date |
---|---|
JP2013540135A (en) | 2013-10-31 |
WO2012068714A1 (en) | 2012-05-31 |
JP5902184B2 (en) | 2016-04-13 |
KR20180080368A (en) | 2018-07-11 |
KR20150136544A (en) | 2015-12-07 |
KR20130060326A (en) | 2013-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100238355B1 (en) | Hair restorer | |
JP4195763B2 (en) | Hair lotion with improved properties in protecting hair and preventing hair loss as well as exogenous effects of androgenic alopecia and resulting reduction in hair loss | |
JP4603192B2 (en) | Hair scalp composition | |
EP3178465A1 (en) | Methods for treating baldness and promoting hair growth | |
US9622963B2 (en) | Methods for stimulating growth and preventing loss of human hair | |
KR102035812B1 (en) | Hair growth promoter | |
CN105106027B (en) | hair growth enhancer | |
EP0540854A2 (en) | Preparation for promoting hair growth | |
EP0659080B1 (en) | Method for the treatment of hair loss | |
JP2006028026A (en) | Hair-growing agent | |
JP3464591B2 (en) | Hair restoration cosmetics | |
Graczyk et al. | The use of minoxidil in diseases associated with hair loss | |
US10543227B2 (en) | Hair growth composition | |
US9126056B2 (en) | Method of promoting hair growth | |
JP2000016920A (en) | Hair tonic cosmetic | |
JPH1077216A (en) | Hair-restoring cosmetic material | |
JP3624318B2 (en) | Hair nourishing agent | |
JP3717676B2 (en) | Hair nourishing | |
JPH09110645A (en) | Hair nourishing cosmetic | |
TW201143803A (en) | Hair growth promoting composition | |
JPH0995426A (en) | Hair growing cosmetic | |
EP2465581B1 (en) | Non-therapeutic use of a composition for promoting hair growth | |
JPH1112134A (en) | Composition for head | |
CA2874288A1 (en) | Composition for hair growth | |
KR20010056211A (en) | A hair restorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
PA0104 | Divisional application for international application |
Comment text: Divisional Application for International Patent Patent event code: PA01041R01D Patent event date: 20151118 Application number text: 1020137009608 Filing date: 20130416 |
|
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20151120 Comment text: Request for Examination of Application |
|
PG1501 | Laying open of application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170928 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20180330 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20170928 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20180330 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20171123 Comment text: Amendment to Specification, etc. Patent event code: PX09012R01I Patent event date: 20170801 Comment text: Amendment to Specification, etc. |
|
PX0601 | Decision of rejection after re-examination |
Comment text: Decision to Refuse Application Patent event code: PX06014S01D Patent event date: 20180530 Comment text: Amendment to Specification, etc. Patent event code: PX06012R01I Patent event date: 20180430 Comment text: Decision to Refuse Application Patent event code: PX06011S01I Patent event date: 20180330 Comment text: Amendment to Specification, etc. Patent event code: PX06012R01I Patent event date: 20171123 Comment text: Notification of reason for refusal Patent event code: PX06013S01I Patent event date: 20170928 Comment text: Amendment to Specification, etc. Patent event code: PX06012R01I Patent event date: 20170801 |
|
A107 | Divisional application of patent | ||
J201 | Request for trial against refusal decision | ||
PA0104 | Divisional application for international application |
Comment text: Divisional Application for International Patent Patent event code: PA01041R01D Patent event date: 20180703 Application number text: 1020137009608 Filing date: 20130416 |
|
PJ0201 | Trial against decision of rejection |
Patent event date: 20180703 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20180530 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Patent event date: 20180330 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20190930 Appeal identifier: 2018101002846 Request date: 20180703 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018101002846; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20180703 Effective date: 20190930 |
|
PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20190930 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 20180703 Decision date: 20190930 Appeal identifier: 2018101002846 |
|
PS0901 | Examination by remand of revocation | ||
S901 | Examination by remand of revocation | ||
GRNO | Decision to grant (after opposition) | ||
PS0701 | Decision of registration after remand of revocation |
Patent event date: 20191011 Patent event code: PS07012S01D Comment text: Decision to Grant Registration Patent event date: 20191002 Patent event code: PS07011S01I Comment text: Notice of Trial Decision (Remand of Revocation) |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20191017 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20191017 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20221017 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20241016 Start annual number: 6 End annual number: 6 |